CryoPort (CYRX) vs Latigo Biotherapeutics (LTGO)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
CryoPort is the larger company by market cap ($964.9 million vs $861.9 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CYRX | LTGO |
|---|---|---|
| Share price | $19.05 | $13.00 |
| Market cap | $964.87M | $861.89M |
| 1-day change | -2.56% | -1.81% |
| YTD return | +98.44% | — |
| 1-year return | +116.97% | — |
| 5-year return | -71.38% | — |
| EPS (TTM) | $-0.90 | $-6.07 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $176.18M | — |
| Revenue growth (YoY) | +12.38% | — |
| Net income (latest FY) | $78.30M | — |
| Gross margin | 47.14% | — |
| Operating margin | -20.89% | — |
| Net margin | 44.44% | — |
| 52-week high | $21.78 | $25.93 |
| 52-week low | $7.61 | $10.24 |
| Distance from 52-week high | -12.53% | -49.87% |
| Analyst consensus | strong_buy | strong_buy |
| Avg. price target upside | +17.22% | +301.92% |
| Average volume | 843.80K | 309.60K |
| Shares outstanding | 50.65M | 66.30M |
| Employees | 684 | 66 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About CryoPort
CYRX stock →Cryoport, Inc. provides temperature-controlled supply chain solutions in biopharma/pharma, animal health, and reproductive medicine markets worldwide.
Health Care · Biotechnology: Pharmaceutical Preparations · 684 employees
About Latigo Biotherapeutics
LTGO stock →Latigo Biotherapeutics, Inc. develops non-opioid pain medicines designed to stop the transmission of pain without the risk of addiction.
Health Care · Biotechnology: Pharmaceutical Preparations · 66 employees
CYRX vs LTGO FAQ
Which is bigger, CryoPort or Latigo Biotherapeutics?
CryoPort (CYRX) is larger, with a market capitalization of $964.87M compared with $861.89M for Latigo Biotherapeutics (LTGO).
Are CryoPort and Latigo Biotherapeutics in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.